Johnson & JohnsonvsPrivia Health

JNJ and PRVA stock compared: price, dividend, valuation and results, from SEC filings.

PRVA

Privia Health Group, Inc.

$24.96

Value $3.1B

-0.12%
PRVA's page

Johnson & Johnson (JNJ) has a market value of $660B and Privia Health (PRVA) $3.1B. Over the last year, with dividends, JNJ moved +40.3% and PRVA +7.5%. The P/E is 41.0 for JNJ and 88.8 for PRVA. Dividend yield: JNJ 1.93%, PRVA none.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    JNJ$660B

    PRVA$3.1B

    JNJ is 214 times PRVA

  • Revenue, 12 months

    JNJ$99.3B

    PRVA$2.4B

    JNJ is 41 times PRVA

  • Net income, 12 months

    JNJ$16.1B

    PRVA$35M

    JNJ is 463 times PRVA

  • Operating margin

    JNJ–

    PRVA2.1%

  • ROIC

    JNJ12.4%

    PRVA4.2%

    8.2 points apart

  • P/E

    JNJ41.0

    PRVA88.8

    PRVA is 2.2 times JNJ

  • Dividend yield

    JNJ1.9%

    PRVA0.0%

    1.9 points apart

  • 5-year return

    JNJ+92.9%

    PRVA-19.4%

    112.3 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

JNJ+92.9%

PRVA-19.4%

5010015020020222023202420252026
Returns by period
PeriodJNJWith dividendsPRVAWith dividends
1 year since November 17, 2025+40.3%Price +37.3%+7.5%Price +7.5%
3 years since November 17, 2023+99.1%+25.8% a yearPrice +82.9%+9.0%+2.9% a yearPrice +9.0%
5 years since November 17, 2021+92.9%+14.0% a yearPrice +67.8%-19.4%-4.2% a yearPrice -19.4%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

JNJJohnson & JohnsonPRVAPrivia Health

Valuation

JNJPRVA
Valuation
Price$273.92$24.96
Market value$660B$3.1B
Enterprise value (EV)$688B$2.6B
P/E41.088.8
P/E, 5-year median21.9–
P/B8.13.8
EV/EBIT38.851.8
Free cash flow yield3.1%–

Results and growth

JNJPRVA
Results and growth
Revenue, 12 months$99.3B$2.4B
Net income, 12 months$16.1B$35M
Free cash flow, 12 months$20.6B–
Earnings per share, 12 months$6.59$0.26
Revenue growth, year on year6.1%22.3%
Revenue growth a year, past+2.7%over 5 years+21.0%over 5 years
EPS growth a year, past+14.9%over 5 years-11.4%over 5 years

Margins and returns on capital

JNJPRVA
Margins and returns on capital
Gross margin67.6%–
Operating margin–2.1%
Net margin16.2%1.4%
ROIC12.4%4.2%
ROE19.7%4.6%

Balance sheet

JNJPRVA
Balance sheet
Cash$17.2B$446M
Total debt$44.7B$8.3M
Net debt / EBITDA1.1-7.3
Interest cover18.0×–

Dividends and buybacks

JNJPRVA
Dividends and buybacks
Dividend yield1.9%–
Dividend per share, 12 months$5.28–
Dividend growth a year, past+5.3%over 5 years–
Buyback yield0.9%–
Shareholder yield2.8%–

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: JNJ or PRVA

Didn't find what you were looking for?

Ask us
Which is bigger, Johnson & Johnson or Privia Health?

By market value, Johnson & Johnson ($660B) is about 213.8 times Privia Health ($3.1B), at today's prices.

How did JNJ and PRVA stock do over the last 5 years?

Since November 17, 2021, JNJ's price moved +67.8% and PRVA's -19.4%. With dividends: JNJ +92.9% (+14.0% a year), PRVA -19.4% (-4.2% a year). Past returns do not predict future ones.

Which pays the higher dividend, JNJ or PRVA?

The dividend yield at today's price is 1.93% for Johnson & Johnson and none for Privia Health. Over the last twelve months they paid $5.28 and – per share.

What is the P/E of JNJ and PRVA?

At today's price, the P/E is 41.0 for JNJ and 88.8 for PRVA. It is the share price over the last twelve months' earnings per share.

Which has the higher profit margins, Johnson & Johnson or Privia Health?

Over the last twelve months, the net margin was 16.2% for Johnson & Johnson and 1.4% for Privia Health, and the operating margin – and 2.1%. Revenue was $99.3B and $2.4B.

Which is the better investment, Johnson & Johnson or Privia Health?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.